Paid Clinical Trials Oklahoma City

Discover 715 paid clinical trials in Oklahoma City, Oklahoma. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 715

P-CD19CD20-ALLO1P-CD19CD20-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With B Cell Malignancies

Recruiting

PHASE1

Sponsor:

Poseida Therapeutics, Inc.

Location:

Oklahoma City OK, Dallas TX, Nashville TN, Cincinnati OHshow 5 more

Code:

NCT06014762

Conditions

Diffuse Large B-Cell Lymphoma, Not Otherwise Specified

High-grade B-cell Lymphoma

Primary Mediastinal Large B-cell Lymphoma (PMBCL)

Transformed Follicular Lymphoma (tFL)

Follicular Lymphoma Grade 3B

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

P-CD19CD20-ALLO1

Rimiducid

Observational StudyContinuous Monitoring and Control of Hypoglycemia

Recruiting

Sponsor:

DexCom, Inc.

Location:

Oklahoma City OK, Dallas TX, Amarillo TX, Topeka KSshow 20 more

Code:

NCT03340831

Conditions

Diabetes

Eligibility Criteria

Sex: All

Age: 2+

Healthy Volunteers: Not accepted

Interventions

Continuous Glucose Monitoring (CGM)

NX-1607A Study of NX-1607 in Adults With Advanced Malignancies

Recruiting

PHASE1

Sponsor:

Nurix Therapeutics, Inc.

Location:

Oklahoma City OK, Houston TX, Aurora CO, Chicago ILshow 5 more

Code:

NCT05107674

Conditions

Ovarian Cancer, Epithelial

Gastric Cancer

GastroEsophageal Junction (GEJ) Cancer

Head and Neck Squamous Cell Carcinoma

Metastatic or Unresectable Melanoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

NX-1607

Paclitaxel

Chemotherapy with Endocrine TherapyEvaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Recruiting

PHASE3

Sponsor:

NRG Oncology

Location:

Oklahoma City OK, Lawton OK, Fort Smith AR, Joplin MOshow 715 more

Code:

NCT05879926

Conditions

Breast Cancer

Eligibility Criteria

Sex: Female

Age: 18 - 60

Healthy Volunteers: Not accepted

Interventions

Ovarian Function Suppression + Aromatase Inhibitor

Adjuvant Chemotherapy + Ovarian Function Suppression

EtrasimodAn Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis

Recruiting

Sponsor:

Pfizer

Location:

Oklahoma City OK, Houston TX, Littleton CO, Snellville GAshow 10 more

Code:

NCT06398626

Conditions

Colitis, Ulcerative

Eligibility Criteria

Sex: All

Age: 18 - 64

Healthy Volunteers: Not accepted

Interventions

Etrasimod

Exoskeleton-Assisted Gait TrainingEffects of Exoskeleton-Assisted Gait Training on Functional Rehabilitation Outcomes in Patients With Stroke

Recruiting

Sponsor:

University of Oklahoma

Location:

Oklahoma City OK

Code:

NCT03980457

Conditions

Stroke

Weakness of Extremities as Sequela of Stroke

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Indego Exoskeleton

Standard Rehabilitation

Lenalidomide & DaratumumabS1803, Lenalidomide +/- Daratumumab/rHuPh20 as Post-ASCT Maintenance for MM w/MRD to Direct Therapy Duration

Recruiting

PHASE3

Sponsor:

SWOG Cancer Research Network

Location:

Oklahoma City OK, Lawton OK, Tulsa OK, Fort Smith ARshow 530 more

Code:

NCT04071457

Conditions

Multiple Myeloma

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Lenalidomide

Daratumumab/rHuPH20

CariprazineA Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.

Recruiting

PHASE3

Sponsor:

AbbVie

Location:

Oklahoma City OK, Plano TX, Coppell TX, Dallas TXshow 45 more

Code:

NCT04777357

Conditions

Depression

Bipolar I Disorder

Eligibility Criteria

Sex: All

Age: 10 - 17

Healthy Volunteers: Not accepted

Interventions

Cariprazine

Placebo

Selumetinib vs. Carboplatin/VincristineA Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma

Recruiting

PHASE3

Sponsor:

National Cancer Institute (NCI)

Location:

Oklahoma City OK, Fort Worth TX, Dallas TX, Lubbock TXshow 104 more

Code:

NCT03871257

Conditions

Low Grade Glioma

Neurofibromatosis Type 1

Visual Pathway Glioma

Eligibility Criteria

Sex: All

Age: 2 - 21

Healthy Volunteers: Not accepted

Interventions

Carboplatin

Magnetic Resonance Imaging

Quality-of-Life Assessment

Questionnaire Administration

Selumetinib Sulfate

SeralutinibEfficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA)

Recruiting

PHASE3

Sponsor:

GB002, Inc.

Location:

Oklahoma City OK, Plano TX, Dallas TX, Kansas City KSshow 51 more

Code:

NCT05934526

Conditions

Pulmonary Arterial Hypertension

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Placebo

Seralutinib

Generic Dry Powder Inhaler